MayraE.GuerreroMD

Interventional Cardiology

Physician

Dr. Guerrero is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Mayra Guerrero is an Interventional Cardiologist with 20 years of experience in the field. After completing Interventional Cardiology Fellowship at William Beaumont Hospital, she worked at Henry Ford Hospital in Detroit, Michigan for 10 years where she established the Structural Heart Disease Program and the Structural Heart Disease Interventional Fellowship Program. She served as Director of Cardiac Structural Interventions at Evanston Hospital in Evanston, IL from 2015 to 2018. She joined Mayo Clinic in June of 2018 and is currently a Professor of Medicine at Mayo Clinic Hospital in Rochester, MN. Her main area of interest is transcatheter mitral valve replacement (TMVR). She has served as National PI or Co-PI for multiple clinical trials including transcatheter mitral valve repair and replacement. She is Associate Program Director for the Cardiovascular Medicine Fellowship Program and Chair of Diversity and Inclusion for the Department of Cardiovascular Medicine at Mayo Clinic, Rochester, MN.

Corewell Health East Beaumont (Royal Oak)Fellowship, Interventional Cardiology, 2004 - 2005
Chicago Medical School/Rosalind Franklin University of Medicine & ScienceFellowship, Cardiovascular Disease, 2000 - 2003
Chicago Medical School/Rosalind Franklin University of Medicine & ScienceResidency, Internal Medicine, 1996 - 1999
University Auto De Baja California, Esc De MedClass of 1995

PubMed

Valve Thrombosis and Antithrombotic Therapy After Bioprosthetic Mitral Valve Replacement: A Systematic Review And Meta-Analysis.
Mark J Zorman, Jonathan Vibhishanan, Katerina Dangas, James Castle, Ka Hou Christien Li
European Heart Journal. Cardiovascular Pharmacotherapy. 2025-02-04
Management of acute decompensated valvular heart disease.
Enzo Lüsebrink, Hugo Lanz, Antonia Kellnar, Nicole Karam, Samir Kapadia
European Journal of Heart Failure. 2024-12-11
Transcatheter Aortic Valve Implantation by Valve Type in Women With Small Annuli: Results From the SMART Randomized Clinical Trial.
Didier Tchétché, Roxana Mehran, Daniel J Blackman, Ramzi F Khalil, Helge Möllmann
JAMA Cardiology. 2024-12-01

Lectures

All You Need to Know About MitraClip: Case Selection and Procedural Steps
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/25/2019
Mitral Valve-in-Valve: 1-Year Outcomes of Transcatheter Mitral Valve Replacement for Degenerated Mitral Bioprotheses
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
MAC Management: Transseptal Valve in MAC
CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/14/2019
ACC Panelist
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
Aortic Valve Interventions: New Indications
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
Mitral Valve Interventions
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
Joint American College of Cardiology/New England Journal of Medicine Late-Breaking Clinical Trials
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
Transcatheter Valve Repair/Replacement: Expanding Indications
2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
Join now to see all

Residual TR After Treating Mitral ViV Disease Linked to Worse OutcomesNovember 26th, 2024
Quality Improvement for Institutions | Enhancing Practice and Patient Outcomes with NCDR’s Real-World DataJune 28th, 2024
Doctors See Uptick in Women's Heart Disease and Stroke During PandemicJune 5th, 2022
Join now to see all